67 related articles for article (PubMed ID: 2586466)
1. [Clinical significance of measurement of nuclear DNA content in breast cancer].
Nishi T; Okajima K; Taguchi T; Ryo T; Sekimoto T
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1559-63. PubMed ID: 2586466
[TBL] [Abstract][Full Text] [Related]
2. [Malignancy grading in breast cancer as assessed by nuclear DNA content].
Nishi T; Okajima K; Taguchi T; Mizutani H; Sogabe T; Uragami I; Sekimoto T
Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):576-81. PubMed ID: 3405196
[TBL] [Abstract][Full Text] [Related]
3. [Nuclear DNA content in breast cancer in relation to postoperative recurrence].
Nishi T; Okajima K; Taguchi T; Ryo T; Osada K; Kanemoto H
Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):459-63. PubMed ID: 1870575
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of nuclear DNA content in breast cancer].
Nishi T; Okajima K; Taguchi T; Ryo T; Mizutani H; Kawashima Y; Sekimoto T
Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):569-77. PubMed ID: 2351850
[TBL] [Abstract][Full Text] [Related]
5. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
7. [Nuclear DNA content in nasopharyngeal carcinoma (NPC) cells].
Shen ZY; Li MJ; Li QS
Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):435-7. PubMed ID: 3582111
[TBL] [Abstract][Full Text] [Related]
8. Deoxyribonucleic acid (DNA) content of primary carcinoma and response to endocrine or cytotoxic drug therapies in patients with advanced breast cancer.
Mitchell I; Deshpande N; Millis R; Rubens RD
Eur J Surg Oncol; 1985 Sep; 11(3):251-6. PubMed ID: 4029405
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
10. [Biological characteristics of breast cancers with various DNA content].
Loboda VI
Vopr Onkol; 1980; 26(12):23-8. PubMed ID: 7467215
[TBL] [Abstract][Full Text] [Related]
11. [Impulse cytophotometry and catamnesis in breast neoplasms].
Krug H; Schönfelder M
Acta Histochem Suppl; 1984; 30():117-27. PubMed ID: 6425932
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between nuclear DNA content and cellular morphology in endometrial cancer--analysis by cell sorting with flow cytometry].
Sugita M; Tenjin Y
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Feb; 38(2):195-202. PubMed ID: 3958516
[TBL] [Abstract][Full Text] [Related]
13. [Surgical procedure and adjuvant therapy in breast cancer].
Ishida T; Izuo M
Rinsho Hoshasen; 1989 Apr; 34(4):435-42. PubMed ID: 2746940
[TBL] [Abstract][Full Text] [Related]
14. Karyometric and DNA content analyses of cancer cells in stage III breast cancer with reference to prognosis.
Tamura G; Masuda T; Satoh T; Satodate R; Ishida M; Saitoh K
Jpn J Clin Oncol; 1990 Mar; 20(1):78-82. PubMed ID: 2157083
[TBL] [Abstract][Full Text] [Related]
15. Prediction of relapse in patients with breast cancer by DNA cytometry.
Machado-Santelli GM; Mori L; Pereira CA
Anal Cell Pathol; 1994 Dec; 7(4):321-34. PubMed ID: 7696156
[TBL] [Abstract][Full Text] [Related]
16. Cytophotometric measurements of nuclear DNA content values in human breast lesions.
Enchev VG; Dobreva PV
Arch Geschwulstforsch; 1987; 57(1):31-7. PubMed ID: 3566463
[TBL] [Abstract][Full Text] [Related]
17. Use of nuclear image cytometry, histopathological grading and DNA cytometry to make breast cancer prognosis more objective.
Theissig F; Dimmer V; Haroske G; Kunze KD; Meyer W
Anal Cell Pathol; 1991 Nov; 3(6):351-60. PubMed ID: 1751402
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
[TBL] [Abstract][Full Text] [Related]
19. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis.
Tamura G; Maesawa C; Mikawa S; Satodate R
Jpn J Clin Oncol; 1991 Aug; 21(4):264-7. PubMed ID: 1682519
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
